87 related articles for article (PubMed ID: 22829937)
1. Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.
Liu L; Zhang CZ; Cai M; Fu J; Chen GG; Yun J
PLoS One; 2012; 7(7):e41293. PubMed ID: 22829937
[TBL] [Abstract][Full Text] [Related]
2. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma.
Wang Y; Chen CL; Pan QZ; Wu YY; Zhao JJ; Jiang SS; Chao J; Zhang XF; Zhang HX; Zhou ZQ; Tang Y; Huang XQ; Zhang JH; Xia JC
Oncotarget; 2016 Feb; 7(5):6323-34. PubMed ID: 26575170
[TBL] [Abstract][Full Text] [Related]
3. Polo-Like Kinase 4 Correlates with Aggressive Tumor Characteristics, Shortened Disease-Free Survival and Overall Survival in Patients with Cutaneous Melanoma who Undergo Surgical Resection.
Zhang L; Zhang S; Han Z; Liu Z; Xu Y; Li X; Miao G; Niu L
Tohoku J Exp Med; 2024 Apr; 262(4):253-261. PubMed ID: 37940564
[TBL] [Abstract][Full Text] [Related]
4. Tumor polo-like kinase 4 protein expression reflects lymphovascular invasion, higher Federation of Gynecology and Obstetrics stage, and shortened survival in endometrial cancer patients who undergo surgical resection.
Zhao Q; Wang M; Chen M
BMC Womens Health; 2024 Feb; 24(1):101. PubMed ID: 38326803
[TBL] [Abstract][Full Text] [Related]
5. Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management.
Garvey DR; Chhabra G; Ndiaye MA; Ahmad N
Mol Cancer Ther; 2021 Apr; 20(4):632-640. PubMed ID: 33402398
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of targeting polo-like kinase 4.
Lei Q; Yu Q; Yang N; Xiao Z; Song C; Zhang R; Yang S; Liu Z; Deng H
Eur J Med Chem; 2024 Feb; 265():116115. PubMed ID: 38199166
[TBL] [Abstract][Full Text] [Related]
7. Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB).
Bailey AW; Suri A; Chou PM; Pundy T; Gadd S; Raimondi SL; Tomita T; Sredni ST
Bioengineering (Basel); 2018 Nov; 5(4):. PubMed ID: 30400339
[TBL] [Abstract][Full Text] [Related]
8. Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy.
Zhang X; Wei C; Liang H; Han L
Front Oncol; 2021; 11():587554. PubMed ID: 33777739
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells.
Xie XL; Zhu HX; Li YM; Chen DT; Fan TY
Cell Cycle; 2020 Apr; 19(8):884-894. PubMed ID: 32200684
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer.
Zhou Q; Fan G; Dong Y
J Clin Lab Anal; 2020 Apr; 34(4):e23152. PubMed ID: 31876063
[TBL] [Abstract][Full Text] [Related]
11. PLK4: a promising target for cancer therapy.
Zhao Y; Wang X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2413-2422. PubMed ID: 31492983
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer.
Suri A; Bailey AW; Tavares MT; Gunosewoyo H; Dyer CP; Grupenmacher AT; Piper DR; Horton RA; Tomita T; Kozikowski AP; Roy SM; Sredni ST
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035676
[TBL] [Abstract][Full Text] [Related]
13. High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer.
He Y; Wang H; Yan M; Yang X; Shen R; Ni X; Chen X; Yang P; Chen M; Lu X; Shao G; Zhou X; Shao Q
Mol Med Rep; 2018 Dec; 18(6):5327-5336. PubMed ID: 30365085
[TBL] [Abstract][Full Text] [Related]
14. MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway.
Bao J; Yu Y; Chen J; He Y; Chen X; Ren Z; Xue C; Liu L; Hu Q; Li J; Cui G; Sun R
Cell Death Dis; 2018 Oct; 9(10):1045. PubMed ID: 30315225
[TBL] [Abstract][Full Text] [Related]
15. Human male infertility and its genetic causes.
Miyamoto T; Minase G; Shin T; Ueda H; Okada H; Sengoku K
Reprod Med Biol; 2017 Apr; 16(2):81-88. PubMed ID: 29259455
[TBL] [Abstract][Full Text] [Related]
16. Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy.
Li Z; Dai K; Wang C; Song Y; Gu F; Liu F; Fu L
J Cancer; 2016; 7(9):1125-32. PubMed ID: 27326256
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
